$25.47
0.22[0.87%]
At close: May 10
$25.47
0[0.00%]
After Hours: 4:00PM EDT
Myriad Genetics
(NASDAQ:MYGN)Myriad Genetics Stock (NASDAQ:MYGN), Quotes and News Summary
Myriad Genetics Stock (NASDAQ: MYGN) stock price, news, charts, stock research, profile.
| Open | $25.160 |
| Close | $25.470 |
| Volume / Avg. | 1.135M / 703.782K |
| Day Range | 24.990 - 25.950 |
| 52 Wk Range | 13.820 - 25.280 |
| Market Cap | $2.305B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 79 |
| Short Interest | 8.52% |
| Days to Cover | 9.94 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Myriad Genetics (MYGN) stock?
You can purchase shares of Myriad Genetics (NASDAQ: MYGN) through any online brokerage.
Who are Myriad Genetics's (MYGN) competitors?
Other companies in Myriad Genetics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), Syndax Pharmaceuticals (NASDAQ:SNDX) and TG Therapeutics (NASDAQ:TGTX).
What is the target price for Myriad Genetics (MYGN) stock?
The latest price target for Myriad Genetics (NASDAQ: MYGN) was reported by Leerink Partners on Wednesday, May 8, 2024. The analyst firm set a price target for 35.00 expecting MYGN to rise to within 12 months (a possible 37.42% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Myriad Genetics (MYGN)?
The stock price for Myriad Genetics (NASDAQ: MYGN) is $25.47 last updated May 10, 2024 at 4:00 PM EDT.
Does Myriad Genetics (MYGN) pay a dividend?
There are no upcoming dividends for Myriad Genetics.
When is Myriad Genetics (NASDAQ:MYGN) reporting earnings?
Myriad Genetics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Myriad Genetics (MYGN) going to split?
There is no upcoming split for Myriad Genetics.
What sector and industry does Myriad Genetics (MYGN) operate in?
Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.